Literature DB >> 10691794

Blood pressure control in eNOS knock-out mice: comparison with other species under NO blockade.

H M Stauss1, B Nafz, R Mrowka, P B Persson.   

Abstract

Changes in arterial blood pressure (ABP) lead to changes in vascular shear stress. This mechanical stimulus increases cytosolic Ca2+ in endothelial cells, which in turn activates the endothelial isoform of the nitric oxide synthase. The subsequently formed NO reaches the adjacent vascular smooth muscle cells, where it reduces vascular resistance in order to maintain ABP at its initial level. Thus, NO may play an important role as a physiological blood pressure buffer. Previous data on the importance of eNOS for blood pressure control are reviewed with special emphasis on the fact that endogenous nitric oxide can buffer blood pressure variability (BPV) in dogs, rats and mice. In previous studies where all isoforms of the nitric oxide synthase were blocked pharmacologically, increases in blood pressure and variability were observed. Thus, we set out to clarify which isoform of the nitric oxide synthase is responsible for this BPV controlling effect. Hence, blood pressure control was studied in knock-out mice lacking specifically the gene for endothelial nitric oxide synthase with their respective wild-type controls. One day after surgery, under resting conditions, blood pressure was increased by 47 mmHg (P < 0.05), heart rate was lower (-77 beats min-1, P < 0.05), and BPV doubled (P < 0.05). Based on these results, we conclude that chronic blood pressure levels are influenced by eNOS and that there is a blood pressure buffering effect of endogenous nitric oxide which is mediated by the endothelial isoform of the nitric oxide synthase.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10691794     DOI: 10.1046/j.1365-201x.2000.00639.x

Source DB:  PubMed          Journal:  Acta Physiol Scand        ISSN: 0001-6772


  7 in total

1.  The role of nitric oxide in the mechanical repression of RANKL in bone stromal cells.

Authors:  Jill Rahnert; Xian Fan; Natasha Case; Tamara C Murphy; Francesco Grassi; Buer Sen; Janet Rubin
Journal:  Bone       Date:  2008-03-20       Impact factor: 4.398

2.  Exercise conditioning attenuates the hypertensive effects of nitric oxide synthase inhibitor in rat.

Authors:  Kazim Husain
Journal:  Mol Cell Biochem       Date:  2002-02       Impact factor: 3.396

3.  Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice.

Authors:  Kehuan Luo; Larry G Thaete; Mark G Neerhof
Journal:  Reprod Sci       Date:  2016-01-19       Impact factor: 3.060

4.  Increased nitric oxide and attenuated diastolic blood pressure variability in african americans with mildly impaired renal function.

Authors:  Keith M Diaz; Deborah L Feairheller; Kathleen M Sturgeon; Praveen Veerabhadrappa; Sheara T Williamson; Deborah L Crabbe; Michael D Brown
Journal:  Int J Hypertens       Date:  2011-01-09       Impact factor: 2.420

5.  Endothelial Retargeting of AAV9 In Vivo.

Authors:  Tarik Bozoglu; Seungmin Lee; Tilman Ziegler; Victoria Jurisch; Sanne Maas; Andrea Baehr; Rabea Hinkel; Amelie Hoenig; Anjana Hariharan; Christina Inyeop Kim; Simon Decker; Haider Sami; Tobias Koppara; Ruppert Oellinger; Oliver J Müller; Derk Frank; Remco Megens; Peter Nelson; Christian Weber; Angelika Schnieke; Markus Sperandio; Gianluca Santamaria; Roland Rad; Alessandra Moretti; Karl-Ludwig Laugwitz; Oliver Soehnlein; Manfred Ogris; Christian Kupatt
Journal:  Adv Sci (Weinh)       Date:  2022-01-12       Impact factor: 16.806

Review 6.  Tetrahydrobiopterin in cardiovascular health and disease.

Authors:  Jennifer K Bendall; Gillian Douglas; Eileen McNeill; Keith M Channon; Mark J Crabtree
Journal:  Antioxid Redox Signal       Date:  2014-03-14       Impact factor: 8.401

7.  Elevated Neuropeptide Y in Endothelial Dysfunction Promotes Macrophage Infiltration and Smooth Muscle Foam Cell Formation.

Authors:  Bongkun Choi; Min-Kyung Shin; Eun-Young Kim; Ji-Eun Park; Halim Lee; Seong Who Kim; Jae-Kwan Song; Eun-Ju Chang
Journal:  Front Immunol       Date:  2019-07-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.